A detailed history of Mark Sheptoff Financial Planning, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Mark Sheptoff Financial Planning, LLC holds 13 shares of NVO stock, worth $1,105. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13
Previous 13 -0.0%
Holding current value
$1,105
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$122.71 - $146.91 $36,813 - $44,073
-300 Reduced 95.85%
13 $1,000
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $30,633 - $40,775
300 Added 2307.69%
313 $40,000
Q3 2023

Nov 09, 2023

BUY
$90.94 - $199.54 $1,182 - $2,594
13 New
13 $1,000
Q4 2018

Feb 11, 2019

SELL
$41.54 - $47.25 $74,772 - $85,050
-1,800 Closed
0 $0
Q2 2018

Aug 09, 2018

BUY
$44.29 - $50.42 $79,722 - $90,756
1,800 New
1,800 $83,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mark Sheptoff Financial Planning, LLC Portfolio

Follow Mark Sheptoff Financial Planning, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mark Sheptoff Financial Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mark Sheptoff Financial Planning, LLC with notifications on news.